Angiotensin-converting enzyme inhibition by enalapril: A novel approach to reduce ischemia/reperfusion damage after experimental liver transplantation

Hepatology

Volumn 25, Issue 3, 1997, Pages 648-651

  Anthuber, Matthias ^a,d   Farkas, Stefan ^b   Rihl, Markus ^b   Menger, Michael D ^c   Schildberg, Friedrich Wilhelm ^b   Jauch, Karl Walter ^a   Messmer, Konrad ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; FIBRINOGEN; LIVER ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE SECRETION; CONTROLLED STUDY; ENZYME INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ADHERENCE; LIVER INJURY; LIVER PROTECTION; LIVER SINUSOID; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTHROMBIN TIME; RAT; REPERFUSION INJURY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ENALAPRIL; ISCHEMIA; LIVER; LIVER TRANSPLANTATION; MALE; MICROCIRCULATION; RATS; RATS, INBRED LEW; REPERFUSION INJURY;

EID: 0031059362     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250326     Document Type: Article

References (17)

1. Bismuth H, Azoulay D, Dennison A. Recent developments in liver transplantation. Transplant Proc 1993;25:2191-2194.
2. Neuhaus P, Blumhardt G, Bechstein WO, Keck H. Progress in the field of liver transplantation in the last 10 years. Langenbecks Arch Chir 1992; 317(suppl):209-216.
3. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993;55:807-813.
4. de Graeff PA, de Langen CDJ, van Gilst WH, Bel K, Scholtens E, Kingma JH, Wesseling H. Protective effects of captopril against ischemia/reperfusion-induced ventricular arrhythmias in vitro and in vivo. Am J Med 1988; 84:67-74.
5. Przyklenk K, Kloner RA. "Cardioprotection" by ACE-inhibitors in acute myocardial ischemia and infarction? Basic Res Cardiol 1993;88(suppl 1): 139-154.
6. Scholkens BA, Linz W. Cardioprotective effects of ACE inhibitors: experimental proof and clinical perspectives. Clin Physiol Biochem 1990;8:33-43.
7. Schroer K. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1992;20(suppl 9):S68-S73.
8. Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979;28:47-56.
9. Post S, Menger MD, Rentsch M, Gonzalez AP, Herfarth C, Messmer K, The impact of arterialization on hepatic microcirculation and leukocyte accumulation after liver transplantation in the rat. Transplantation 1992; 54:789-794.
10. Menger MD, Marzi I, Messmer K. In vivo fluorescence microscopy for quantitative analysis of the hepatic microcirculation in hamsters and rats. Eur Surg Res 1991;23:158-169.
11. Ploeg RJ, D'Alessandro AM, Hoffmann RM, Eckhoff D, Isaacs R, Knechtle SJ, Pirsch JD, et al. Impact of donor factors and preservation on function and survival after liver transplantation. Transplant Proc 1993;25:3031-3033.
12. Belzer FO, D'Alessandro AM, Hoffmann RM, Knechtle SJ, Reed A, Pirsch JD, Kalayoglu M, et al. The use of UW solution in clinical transplantation. A 4-year experience. Ann Surg 1992;215:579-583.
13. Gao WS, Takei Y, Marzi I, Lindert KA, Caldwell-Kenkel JC, Currin RT, Tanaka Y, et al. Carolina rinse solution - a new strategy to increase survival time after orthotopic liver transplantation in the rat. Transplantation 1991;52:417-424.
14. Lemmens HP, Schoen MR, Blumhardt G, Filler D, Brandau O, Meissler M, Baer P, et al. Influence of SOD, catalase, and epoprostenol on 24-hour liver preservation in pigs. Transplant Proc 1993;25:2549-2553.
15. Liang D, Thurman RG. Protective effects of the calcium antagonists diltiazem and TA3090 against hepatic injury due to hypoxia. Biochem Pharmacol 1992;44:2207-2211.
16. Post S, Rentsch M, Palma P, Gonzalez AP, Otto G, Menger MD. Effect of Carolina rinse solution on Kupffer cell activation after reperfusion in rat liver transplantation. Transplant Proc 1992;24:2703.
17. Chopra M, Scott N, McMurray J, McLay J, Bridges A, Smith WE, Belch JJ. Captopril: a free radical scavenger. Br J Clin Pharmacol 1989;27:396-399.